By Payer Type

VA / DoD / Federal Programs Market Analysis

Cross-industry research covering VA / DoD / Federal Programs across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports
1 Industries

Reports Covering VA / DoD / Federal Programs

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

The VA's Million Veteran Program is one of the largest genomic biobanks in the world and generates demand for sequencing instrumentation rather than consumer-facing kits, but its pharmacogenomic implementation arm is creating a model for federal-payer reimbursement that commercial payers monitor closely.

3%

Market Share

8.9%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments